VEGFA and chronic kidney disease: Previous studies have shown that, in swine models of renovascular disease (RVD) and CKD, renal bioavailability of VEGF-A decreased as microvascular rarefaction increased5–7, which was largely offset by intra-renal replenishment of VEGF8 and gave credence to VEGF as a potential therapeutic in the setting RVD.